Table 2.
Eye No. |
Previous Procedure(s) |
Mean Preoperative IOP, mm Hg |
Procedure | 1 wk | 1 mo | 3 mo | 6 mo | 1 y | Preoperative VA |
Postoperative VA |
---|---|---|---|---|---|---|---|---|---|---|
1 | Trab/MMC, revision, TCA 3 times, compression sutures, autologous blood injection |
18 | Bleb reduction, trabeculectomy revision, phaco/IOL |
10 | 11 | 10 | 13 | 14 | 20/100 | 20/20 |
2 | Trab/MMC | 5.3 | Bleb reduction | 8 | 9 | 6 | 9 | 11 | 20/25 | 20/20 |
3 | Trab/MMC | 5.5 | Bleb reduction, phaco/IOL | 24 | 20 | 21a | 15a | 12a | CF | CF |
4 | Trab/MMC | 10.7 | Bleb reduction | 10 | 12 | 10 | 12 | 16 | 20/25 | 20/20 |
5 | Trab/MMC | 10.3 | Bleb reduction | 13 | 11 | 11 | 10 | 10 | 20/20 | 20/20 |
6 | Trab/MMC | 10.5 | Bleb reduction | 9 | 9 | 8 | 8 | 10 | 20/15 | 20/20 |
7 | Trab/MMC | 8 | Bleb reduction | 7 | 7 | 8 | 8 | 7b | 20/200 | 20/20 |
8 | Phaco/IOL, Trab/MMC | 12 | Bleb reduction | 9 | 9 | 9 | 10 | 11 | 20/20 | 20/20 |
9 | Trab/MMC, cryotherapy, TCA, phaco/IOL |
11 | Bleb reduction | 22 | 26a | 19a | 16a | 18a | 20/25 | 20/30+2 |
10 | Trab/MMC | 8.7 | Bleb reduction | 10 | 9 | 8 | 9 | 11 | 20/25−1 | 20/25−2 |
11 | Trab/MMC, ALT | 15 | Bleb reduction, phaco/IOL | 16 | 16a | 19a | 15a | 15a | 20/40 | 20/20 |
12 | Trab/MMC | 11.6 | Bleb reduction | 13 | 13 | 12 | 12 | 16 | 20/150 | 20/150 |
13 | Trab/MMC | 11.5 | Bleb reduction | 11 | 15 | 12 | 12 | 13 | 20/20 | 20/20−3 |
Abbreviations: ALT, argon laser trabeculoplasty; CF, counting fingers visual acuity; IOP, intraocular pressure; phaco/IOL, phacoemulsification with intraocular lens implantation; TCA, topical trichloroacetic acid treatment; Trab/MMC, trabeculectomy with adjunctive mitomycin C; VA, visual acuity.
Patient receiving topical medication to control IOP.
Patient had interval phaco/IOL.